OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Comparison of the mucosal and systemic antibody responses in Covid-19 recovered patients with one dose of mRNA vaccine and unexposed subjects with three doses of mRNA vaccines
Shaojun Liu, Joseph GS Tsun, Genevieve P. G. Fung, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Shaojun Liu, Joseph GS Tsun, Genevieve P. G. Fung, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Showing 6 citing articles:
Seroprevalence and durability of antibody responses to AstraZeneca vaccination in Ugandans with prior mild or asymptomatic COVID-19: implications for vaccine policy
Jennifer Serwanga, Claire Baine, Susan Mugaba, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 10
Jennifer Serwanga, Claire Baine, Susan Mugaba, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 10
Harnessing the potential of the NALT and BALT as targets for immunomodulation using engineering strategies to enhance mucosal uptake
Madison L. Seefeld, Erin L. Templeton, Justin M. Lehtinen, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Madison L. Seefeld, Erin L. Templeton, Justin M. Lehtinen, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Bivalent norovirus mRNA vaccine elicits cellular and humoral responses protecting human enteroids from GII.4 infection
Elena N. Atochina‐Vasserman, Lisa C. Lindesmith, Carmen Mirabelli, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 1
Elena N. Atochina‐Vasserman, Lisa C. Lindesmith, Carmen Mirabelli, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 1
SARS-CoV-2 spike-FLIPr fusion protein plus lipidated FLIPr protects against various SARS-CoV-2 variants in hamsters
Ming-Shu Hsieh, Chia-Wei Hsu, Hung‐Chun Liao, et al.
Journal of Virology (2024) Vol. 98, Iss. 2
Open Access
Ming-Shu Hsieh, Chia-Wei Hsu, Hung‐Chun Liao, et al.
Journal of Virology (2024) Vol. 98, Iss. 2
Open Access
Persistent and robust antibody responses to ChAdOx1-S Oxford-AstraZeneca (ChAdOx1-S, Covishield) SARS-CoV-2 vaccine observed in Ugandans across varied baseline immune profiles
Jennifer Serwanga, Gerald Kevin Oluka, Claire Baine, et al.
PLoS ONE (2024) Vol. 19, Iss. 7, pp. e0303113-e0303113
Open Access
Jennifer Serwanga, Gerald Kevin Oluka, Claire Baine, et al.
PLoS ONE (2024) Vol. 19, Iss. 7, pp. e0303113-e0303113
Open Access
Use of a point-of-care test to rapidly assess levels of SARS-CoV-2 nasal neutralising antibodies in vaccinees and breakthrough infected individuals
Chee Wah Tan, Chuan Kok Lim, Jacqueline Prestedge, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Chee Wah Tan, Chuan Kok Lim, Jacqueline Prestedge, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 1
